[Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine]. / Incidencia de la COVID-19 en pacientes en tratamiento crónico con hidroxicloroquina.
Med Clin (Barc)
; 156(4): 166-171, 2021 02 26.
Article
in English, Spanish
| MEDLINE | ID: covidwho-974362
ABSTRACT
OBJECTIVE:
To analyze the incidence of Covid-19 in patients who are chronic users of hydroxychloroquine. PATIENTS ANDMETHODS:
Cross-sectional retrospective observational multicenter study in health areas and districts from Castilla La-Mancha and Andalucia. Of the 4451 participants included in the first recruitment, 3817 with valid data were selected. The main variable of the study is the presence or absence of Covid-19 infection by clinical, serological or polymerase chain reaction diagnosis. Sociodemographic and clinical variables and treatment and concomitant comorbidities were recorded.RESULTS:
169 (4,45%) patients had Covid-19 infection, of which 12 (7.1%) died and 32 (18.9%) required hospital admission. Previous respiratory pathology was related to Covid-19 infection (P<.05). Maculopathy appears in 5.3% of patients and is significantly related to the dose of hydroxychloroquine consumed (P<.05).CONCLUSION:
There is no relationship between chronic use of hydroxychloroquine and the incidence of Covid-19.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Antirheumatic Agents
/
COVID-19
/
Hydroxychloroquine
/
Lupus Erythematosus, Systemic
Type of study:
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
English
/
Spanish
Journal:
Med Clin (Barc)
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS